[Recommendations in the empiric anti-infective agents of intra-abdominal infection].
A significant number of patients with abdominal infection develop advanced stages of infection and mortality is still above 20%. Failure is multifactorial and is associated with an increase of bacterial resitance, inappropriate empirical treatment, a higher comorbidity of patients and poor source control of infection. These guidelines discuss each of these problems and propose measures to avoid the failure based on the best current scientific evidence.
Guirao
Xavier
X
Sección de Infección Quirúrgica de la AEC. xguirao@teleline.es
Arias
Javier
J
Badía
Josep M A
JM
García-Rodríguez
José A
JA
Mensa
José
J
Alvarez-Lerma
Francisco
F
Borges
Marcio
M
Barberán
José
J
Maseda
Emilio
E
Salavert
Miguel
M
Llinares
Pedro
P
Gobernado
Miguel
M
García Rey
César
C
D000005:Abdomen; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents